XML 50 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHARE-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Summary of the components and classification of share-based compensation expense
The following table summarizes the components and classification of the Company's share-based compensation expenses related to stock options and RSUs for the three and nine months ended September 30, 2022 and 2021:
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in millions)2022202120222021
Stock options$$$10 $11 
RSUs 30 29 81 84 
$33 $33 $91 $95 
Research and development expenses$$$$
Selling, general and administrative expenses30 31 82 88 
$33 $33 $91 $95 
Summary of share-based awards
Share-based awards granted for the nine months ended September 30, 2022 and 2021 consist of:
20222021
Bausch Health Share-Based Awards
Stock options
Granted2,570,000 1,497,000 
Weighted-average exercise price$23.95 $32.44 
Weighted-average grant date fair value$6.60 $11.11 
Time-based RSUs
Granted6,151,000 3,119,000 
Weighted-average grant date fair value$11.76 $31.93 
TSR performance-based RSUs
Granted— 400,000 
Weighted-average grant date fair value$— $56.04 
ROTC performance-based RSUs
Granted369,000 413,000 
Weighted-average grant date fair value$9.40 $31.72 
B+L Separation performance-based RSUs
Granted— 222,000 
Weighted-average grant date fair value$— $28.49 
Bausch+ Lomb Share-Based Awards
Stock options
Granted6,455,000 — 
Weighted-average exercise price$18.00 $— 
Weighted-average grant date fair value$4.55 $— 
Time-based RSUs
Granted4,205,000 — 
Weighted-average grant date fair value$17.22 $—